Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-03

Clinical Trial Update: Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B [Phase 3]

View source ↗

Summary

Phase 3 trial comparing entecavir plus tenofovir versus entecavir alone in treatment-naive chronic hepatitis B patients; the study has completed and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Baraclude (entecavir)
  • Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2012-02-03